Senseonics (NYSE:SENS) Trading Up 6.3% - Time to Buy?

Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) rose 6.3% during mid-day trading on Tuesday . The company traded as high as $0.78 and last traded at $0.77. Approximately 730,253 shares changed hands during mid-day trading, a decline of 88% from the average daily volume of 6,304,260 shares. The stock had previously closed at $0.72.

Wall Street Analysts Forecast Growth

Several research firms have commented on SENS. Mizuho began coverage on Senseonics in a report on Thursday, April 10th. They set an "outperform" rating and a $2.00 price objective on the stock. HC Wainwright restated a "buy" rating and set a $2.00 price target on shares of Senseonics in a research note on Wednesday, March 5th.

Senseonics Price Performance

The firm has a market capitalization of $495.90 million, a PE ratio of -5.83 and a beta of 0.84. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The stock has a fifty day moving average price of $0.67 and a 200-day moving average price of $0.61.

Senseonics (NYSE:SENS - Get Free Report) last released its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same quarter in the previous year, the business earned ($0.07) EPS. Sell-side analysts forecast that Senseonics Holdings, Inc. will post -0.14 EPS for the current fiscal year.

Institutional Investors Weigh In On Senseonics

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. First Light Asset Management LLC purchased a new position in shares of Senseonics in the 4th quarter valued at approximately $3,366,000. Geode Capital Management LLC lifted its stake in shares of Senseonics by 9.7% during the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company's stock worth $3,354,000 after buying an additional 566,704 shares during the period. Jane Street Group LLC lifted its stake in shares of Senseonics by 6,694.1% during the fourth quarter. Jane Street Group LLC now owns 6,118,786 shares of the company's stock worth $3,203,000 after buying an additional 6,028,726 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in shares of Senseonics by 9.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,339,698 shares of the company's stock valued at $1,748,000 after buying an additional 274,842 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new position in shares of Senseonics in the 4th quarter valued at $720,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.